-
Jakobsen posted an update 1 year, 4 months ago
12 patients noticed HCP lacked knowledge regarding CAM. The toxicity analysis was carried out for 24 patients who consumed 1 to 24 CAM. 133 CAM were reported, including 87 different CAM. For only 43CAM/87, studies were found. All patients presented ≥1 risk 14 at risk of CAM-Cancer interactions, 15 of CAM-anticancer drug interactions, 21 of CAM direct toxicities. Conclusion Many CAM are used by patients. The diagnosis of cancer favors their use. The risks are manifold low perception of risk that can be induced by CAM, diverse and insecure sources of information and many potential toxicities that are not scientifically documented.Background Pityriasis lichenoides chronica, a papulosquamous disorder often considered a subtype of pityriasis lichenoides. It is considered a clonal T-cell disorder, which may be associated with cutaneous T-cell lymphoma that may develops in response to foreign antigens. Case presentation We present a 38-year-old male patient with ankylosing spondylitis who was on treatment with etanercept. After 8 weeks of treatment, the patient presented with scaly erythematous papules, on the back and arms. He was diagnosed clinically with pityriasis lichenoides chronica. Conclusion Pityriasis lichenoides chronica should be included among the broad clinical spectrum of chronic inflammatory skin diseases which may occur during treatment with TNF-alpha antagonists. J Drugs Dermatol. 2020;19(5) doi10.36849/JDD.2020.2191.Introduction A substantial rate of quotation errors has been reported in medical journal publications about 25% of all quotations are wrong. It is, however, entirely unclear how important quotation errors are for the message of quoting articles. Methods This is a case study in form of a retrospective quotation analysis of a cohort of 72 psychiatric original articles (index articles) from 5 German-language general psychiatric journals. Main outcomes were importance and accuracy of quotations from the 2 calendar years following the publication of index articles. Results Fifty-one index articles were quoted 235 times in 109 quoting articles. Almost all quotations were of medium (76% [95% CI 70%; 81%]) or high (20% [15%, 25%]) importance for the message of the quoting paper. Regarding quotation accuracy, 44 quotations (19% [14%; 24%]) were rated as minor, and 51 (22% [17%; 27%]) as major errors. In multivariable analyses, no statistically significant and practically relevant factors associated with quotation inaccuracy emerged, such as self-quotation, impact factor of the quoting journal, or importance. Among quoting articles, 7 (6% [3%; 13%]) showed a pattern of predominantly quoting index articles from the time span relevant to the calculation of the impact factor. Discussion Quotations are important for the message of the quoting paper. Therefore, quotation errors may be detrimental to scientific reasoning and may undermine public trust in medical science. The present investigation is a case study, and its results are exploratory. While it is plausible that the findings translate into other environments, independent replication is needed.The aim of this study was to examine the expression of the cytokines and chemokines receptor-3 (CCR3) molecules in endothelial cells and vascular structures in a murine model of corneal neovascularization and in samples of neovascularized human corneas. A simple immunofluorescence assay (red only) using the murine model showed a greater proportion and intensity of CCR3 in the epithelium and corneal subepithelial region in corneas with neovascularization. In the absence of vascularization, no CCR3 was found. Of the 32 tissues studied, eight were vascularized and 24 were avascular. In the human corneas, vascularized corneas showed positive labeling for CD31 in all the tissues analyzed, as well as positive labeling in all cases for CCR3. Therefore, all vascularized tissues showed positive coexpression of CCR3 and CD31, whereas none of the avascular corneas showed immunolabeling for either of these receptors.Background Aging signs can be corrected through volume restoration in multiple soft tissue layers and in the supraperiosteal plane using hyaluronic acid (HA) or non-hyaluronic acid (non-HA) fillers. The non-HA bioresorbable polycaprolactone (PCL)-based filler with collagen-stimulating properties has a proven safety profile, but rare potential complications such as nodules and granuloma can occur. Furthermore, PCL-based fillers cannot be immediately removed by injection of an enzyme. These potential drawbacks have yet to be described in the literature. Aims The author performed 1111 treatments between 2015 and 2018. This study aims to review and analyze these treatments to ascertain the complication rates of the PCL-based filler. Suggestions for complication prevention and management are also discussed. Methods 780 patients treated with the PCL-based filler were reviewed by the physician between April 2015 and May 2018. During this period, 5,595 syringes were used in 1111 treatments. All complication data were acquired by phone interviews, reports by patients, or observation at follow-up visits. MLT-748 Complications were subdivided into early-onset (occurring up to 2 weeks after treatment) and late-onset events (occurring more than 2 weeks to years after treatment). Results Among the 1111 treatments, there were 50 cases (4.5%) of edema that lasted longer than 2 weeks, 30 cases (2.7%) of bruising, 8 cases (0.72%) of malar edema, 5 cases (0.45%) of temporarily palpable lumps and 2 cases (0.18%) of discoloration. There were no cases of intravascular injection, nodules/granulomas, or infection. Conclusions The complication rate of the PCL-based filler was found to be low, and there were no cases of intravascular injection, nodules, and/or granulomas during the 3-year observation. Longer-lasting edema was associated with a higher injection volume and malar edema was related to lymphatic compression.Tilimycin is an enterotoxin produced by the opportunistic pathogen Klebsiella oxytoca that causes antibiotic-associated hemorrhagic colitis (AAHC). This pyrrolobenzodiazepine (PBD) natural product is synthesized by a bimodular nonribosomal peptide synthetase (NRPS) pathway comprised of three proteins NpsA, ThdA and NpsB. We describe the functional and structural characterization of the fully reconstituted NRPS system and report the steady-state kinetic analysis of all natural substrates and cofactors as well as the structural characterization of both NpsA and ThdA. The mechanism of action of tilimycin was confirmed using DNA adductomics techniques through the detection of putative N-2 guanine alkylation after tilimycin exposure to eukaryotic cells, providing the first structural characterization of a PBD-DNA adduct formed in cells. Finally, we report the rational design of small-molecule inhibitors that block tilimycin biosynthesis in whole cell K. oxytoca (IC50 = 29 ± 4 µM) through the inhibition of NpsA (KD = 29 ± 4 nM).